Page 254 - 201904
P. 254

·780·                             精细化工   FINE CHEMICALS                                  第 36 卷

                 如表 4 所示,过量的甲酰胺有利于偶联反应的                            positive non-small-cell lung cancer (ARCHER 1050): a randomised,
            进行,目标产物收率显著提高(No.1~4);当甲酰胺                             open-label,  phase  3  trial[J].  Lancet  Oncology,  2017,  18(11):
                                                                   1454-1466.
            用量增加为 BA 的 2 倍后,目标产物收率增加不明                         [3]   Huang Ziling (黄子凌), Huang Lanshan (黄兰姗), Shen Siqiao (沈思
            显(No.3~4)。在 CuI/4-羟基-L-脯氨酸的作用下,                        乔),  et al.  The  influence  on  cell  proliferation  and  apoptosis  of
                                                                   combined  afatinib  with  Mithramycin  A  in  human  hepatocellular
            偶联和环化反应在较低温度下即可进行,但目标产
                                                                   carcinoma  cell  line  HepG2[J].  ACTA  Universitatis  Medicinalis
            物收率较低(No.5~6);当反应温度升高至 80 ℃时,                          Nanjing  (Natural  Science)  (南京医科大学学报:  自然科学版),
            目标产物收率最高(No.3);继续升高反应温度,目                              2015, (5): 638-643.
                                                               [4]   Wang Shengqi (王胜奇). The reversal effect of afatinib on ABCB1-
            标产物收率有所下降(No.7)。在微波促进下,偶联
                                                                   mediated  multidruf  resistance  in  human  ovarian  cancer  and  its
            和环化反应 10 min 即可较好地完成;延长反应时间,                           mechanisms[D]. Guangzhou: Southern Medical University Guangzhou
            目标产物收率反而降低(No.9~10)。                                   (南方医科大学), 2016.
                                                               [5]   Zhao Ying (赵颖), Chi Jiangrui (迟江瑞), Zhao Hongmeng (赵洪猛),
                 综上所述,合成 QA 的优化反应条件为:BA
                                                                   et al. Effect of afatinib on the proliferation and apoptosis of human
            5 mmol,甲酰胺 10 mmol,CuI 用量 10%,4-羟基-L-                  breast cell lines and its mechanisms[J]. Chinese Journal of Clinical
            脯氨酸用量 10%,碳酸钾 10 mmol,DMF 10 mL,微                      Oncology (中国肿瘤临床), 2017, 44(15): 739-743.
                                                               [6]   Hartmann S, Zwick L, Maurus K, et al. Melanoma-associated antigen
            波(200 W)辐射 80 ℃反应 10 min。在此条件下,                        A11 reduces erlotinib and afatinib efficacy in head and neck cancer
            QA 的收率为 96.4%。                                         [J]. Journal of Cranio-Maxillofacial Surgery, 2018, 46(3): 492-497.
                                                               [7]   Endersby R, Whitehouse J, Hii H, et al. A pre-clinical assessment of
            3   结论                                                 the  pan-ERBB  inhibitor  dacomitinib  in  pediatric  and  adult  brain
                                                                   tumors[J]. Neoplasia, 2018, 20(5): 432-442.
                                                               [8]   Cavalieri  S,  Perrone  F,  Miceli  R,  et al.  Efficacy  and  safety  of
                 以 2-溴-4-氟-5-硝基苯甲腈为原料,在 CuI 和微
                                                                   single-agent  pan-human  epidermal  growth  factor  receptor  (HER)
            波促进下,与 3-氯-4-氟苯胺发生加成反应得到中                              inhibitor dacomitinib in locally advanced unresectable or metastatic
            间产物 BA,收率 93.8%,得到的优化反应条件为:                            skin squamous cell cancer[J]. European Journal of Cancer, 2018, 97:
                                                                   7-15.
            2-溴-4-氟-5-硝基苯甲腈 10  mmol,3-氯-4-氟苯胺
                                                               [9]   Tu Yuanbiao (涂远彪), Wang Min (王敏), Sun Chao (孙超), et al.
            10 mmol,CuI 用量 20%,无水乙醇 10  mL,微波                      Synthesis and optimization of antitumor agent afatinib[J]. Chemical
            (200 W)辐射回流反应 20  min;然后,以 CuI/4-                      Reagents (化学试剂), 2016, 38(8): 795-799.
                                                               [10]  Cheng Haibo (程海博), Xu Bin (徐斌), Zhang Huibin (张惠斌), et
            羟基-L-脯氨酸作催化剂,碳酸钾作碱,微波促进下                               al.  Synthetic  process  of  antitumor  drug  dacomitinib[J].  Journal  of
            与甲酰胺发生串联的胺化和缩合环化反应,以                                   China  Pharmaceutical  University  Nanjing  (中国药科大学学报),
            96.4%的收率得到目标产物 QA,得到的优化反应条                             2014, 45(2): 165-169.
                                                               [11]  Soyka R, Rall W,  Schnaubelt J, et al. Process for preparing amino
            件为:BA 5 mmol,甲酰胺 10 mmol,CuI 和 4-羟基-L-                 crotonyl compound:US2007/0027170A1[P]. 2007-02-01.
            脯氨酸用量均为 10%,碳酸钾 10  mmol,DMF                       [12]  Zhang  Q,  Zhu  H.  Novel  quinazoline  derivatives:  US2013/0035350A1
            10 mL,微波(200 W)辐射 80 ℃反应 10  min。该                     [P]. 2013-02-07.
                                                               [13]  Cha M Y, Lee K, Woo J, et al. Discovery of a novel Her-1/Her-2 dual
            方法合成路线短,反应条件温和,反应时间短,产                                 tyrosine kinase inhibitor for the treatment of Her-1 selective inhibitor-
            物收率高,避免使用氯化亚砜和三氯氧磷,对环境                                 resistant non-small cell lung cancer[J]. J Med Chem, 2009, 52: 6880-
            较为友好,为合成 4-喹唑啉胺类化合物提供了一种                               6888.
                                                               [14]  Liu  Changchun  (刘长春).  Synthesis  of  2,6-dimethyl-3-aryl-4  (1H)-
            高效的简便方法,具有潜在的工业化应用前景。                                  quinolones under microwave irradiation[J]. Fine Chemicals (精细化
                                                                   工), 2014, 31(1): 75-78.
            参考文献:                                              [15]  Zong Chaoyang (纵朝阳), Gu Huiwen (顾惠雯), Zhang Lijie (张立
            [1]   Wang  Debby  D,  Lee  Victor  H  F,  Zhu  Guangyu,  et al.  Selectivity   洁),  et al.  Microwave-accelerated  Dimroth  rearrangement  for  the
                 profile of afatinib for EGFR-mutated non-small-cell lung cancer[J].   synthesis of pyrido [2,3-d] pyrimidin-4-amine derivatives[J]. Chin J
                 Mol Biosyst, 2016, 12: 1552-1563.                 Org Chem (有机化学), 2018, 38(5): 1165-1171.
            [2]   Wu Yilong, Cheng Ying, Zhou Xiangdong, et al. Dacomitinib versus   [16]  Zhang W, Su W G, Yang H, et al. Quinazoline derivatives: US2013/
                 gefitinib as first-line treatment for patients with EGFR-mutation-     0217761A1[P]. 2013-08-22.
   249   250   251   252   253   254   255   256   257   258   259